What is the average Polivy (polatuzumab vedotin) patient age in clinical trials?
I don’t have enough provided information to calculate an “average” Polivy patient age across its trials. Trial publications usually report age as a range (for example, “median age” with interquartile range, or “range from X to Y”) rather than a single cross-trial mean, and the average would also depend on which study (or which line of therapy) you mean.
Which Polivy trial are you asking about?
Polivy was studied in different settings (commonly with bendamustine/rituximab, and with R-CHP for diffuse large B-cell lymphoma). Each trial has different age summaries. If you tell me the specific study name or regimen (for example, the trial ID or indication), I can report the age statistic that study provides (median/mean, range) and help you interpret it.
What I can do next if you share the trial
If you paste the trial’s age table/results section (or tell me the trial name/ID and indication), I can:
- extract the reported age metric (mean vs median),
- clarify the age range and sample size,
- compute a weighted average if the necessary per-arm numbers are available.
Quick clarifying question
Which trial/regimen do you mean (e.g., “Polivy + bendamustine/rituximab” or “Polivy + R-CHP,” and the trial ID if you have it)?